Recent News

• 12.03.2025 - EFFECT - Notice of Effectiveness
• 12.02.2025 - 424B3 - Prospectus [Rule 424(b)(3)]
• 11.26.2025 - 8-K - Current report
• 11.14.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
• 11.14.2025 - 8-K - Current report
• 11.14.2025 - GT Biopharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update
• 10.24.2025 - S-1 - General form for registration of securities under the Securities Act of 1933
• 10.08.2025 - GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
• 10.06.2025 - GT Biopharma to Participate in the Centurion One Capital 3rd Annual Bahamas Summit
• 09.26.2025 - 8-K - Current report

Recent Filings

• 11.26.2025 - 8-K Current report
• 11.14.2025 - EX-99.1 EX-99.1
• 11.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.14.2025 - 8-K Current report
• 10.24.2025 - S-1 General form for registration of securities under the Securities Act of 1933
• 09.26.2025 - 8-K Current report
• 09.23.2025 - 8-K Current report